Association of depression with medical illness: Does cortisol play a role?

被引:402
作者
Brown, ES
Varghese, FP
McEwen, BS
机构
[1] Univ Texas, SW Med Ctr, Dept Psychiat, Psychoneuroendocrine Res Program, Dallas, TX 75390 USA
[2] Rockefeller Univ, Howard & Margaret Milliken Lab Neuroendocrinol, New York, NY 10021 USA
关键词
depression; hippocampus; waist-to-hip ratio; osteoporosis; Cushing's syndrome; metabolic syndrome;
D O I
10.1016/S0006-3223(03)00473-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Elevated cortisol in a subset of depressed patients is an enduring and well-replicated finding. Much interest has focused on the possible effects of depression on the hippocampus; however, an emerging body of evidence suggests an association between depression and non-central nervous system illnesses, In this review, data on the effects of depression on the brain and other organ systems sensitive to elevated cortisol are discussed. From searches of the MEDLINE, PSYCHINFO, and Current Contents databases, and other sources, articles were found specifically related to depression and physical changes or medical conditions associated with corticosteroid excess in patients with Cushing's disease, including cognitive impairment, hippocampal atrophy, increased waist-to-hip ratio, bone loss, hypertension, diabetes, peptic ulcers, and hyperlipidemia. Data are strongest for a relationship between elevated cortisol and depression, hippocampal atrophy, cognitive impairment, abdominal obesity, and loss of bone density. Some evidence suggests an association between depression and hypertension, peptic ulcers, and diabetes. Depression does not appear to be associated with hyperlipidemia. The data provide some support for similar health effects in depressed patients and patients with Cushing's disease or the metabolic syndrome; however, additional studies are needed relating systemic effects of depression to cortisol. Limitations of the current literature, treatment implications, and possible directions for future research are discussed. (C) 2004 Society of Biological Psychiatry.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 126 条
  • [1] The prevalence of comorbid depression in adults with diabetes - A meta-analysis
    Anderson, RJ
    Freedland, KE
    Clouse, RE
    Lustman, PJ
    [J]. DIABETES CARE, 2001, 24 (06) : 1069 - 1078
  • [2] [Anonymous], 1999, Diagnostic and statistical manual of mental disorders
  • [3] URINARY FREE CORTISOL IN PSYCHOTIC DEPRESSION
    ANTON, RF
    [J]. BIOLOGICAL PSYCHIATRY, 1987, 22 (01) : 24 - 34
  • [4] ARANA GW, 1985, ARCH GEN PSYCHIAT, V42, P1193
  • [5] HYPERCORTISOLEMIA AND HIPPOCAMPAL CHANGES IN DEPRESSION
    AXELSON, DA
    DORAISWAMY, PM
    MCDONALD, WM
    BOYKO, OB
    TUPLER, LA
    PATTERSON, LJ
    NEMEROFF, CB
    ELLINWOOD, EH
    KRISHNAN, KRR
    [J]. PSYCHIATRY RESEARCH, 1993, 47 (02) : 163 - 173
  • [6] An open label trial of C-1073 (mifepristone) for psychotic major depression
    Belanoff, JK
    Rothschild, AJ
    Cassidy, F
    DeBattista, C
    Baulieu, EE
    Schold, C
    Schatzberg, AF
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 52 (05) : 386 - 392
  • [7] Corticosteroids and cognition
    Belanoff, JK
    Gross, K
    Yager, A
    Schatzberg, AF
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2001, 35 (03) : 127 - 145
  • [8] Cortisol activity and cognitive changes in psychotic major depression
    Belanoff, JK
    Kalehzan, M
    Sund, B
    Ficek, SKF
    Schatzberg, AF
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (10) : 1612 - 1616
  • [9] Hippocampal volume reduction in major depression
    Bremner, JD
    Narayan, M
    Anderson, ER
    Staib, LH
    Miller, HL
    Charney, DS
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) : 115 - 117
  • [10] Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders
    Brown, ES
    Rush, AJ
    McEwen, BS
    [J]. NEUROPSYCHOPHARMACOLOGY, 1999, 21 (04) : 474 - 484